FDA Approves Portola Drug Betrixaban For Blood Clot Prevention The Food and Drug Administration has approved betrixaban for preventing blood clotting among patients with deep vein thrombosis. The oral treatment is the first extended duration treatment for hospitalized acutely ill patients. by Alyssa Navarro
Healthy Living/Wellness Varicose Veins, Leg Pain May Indicate More Serious Health Problem by Angela Laguipo
Healthy Living/Wellness Testosterone products increase blood clot risks, must have general warning label: FDA by Tina Shah
Healthy Living/Wellness Pregnancy-related blood clot risk lasts 2x longer than previously thought by Rhodilee Jean Dolor